[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630774":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":24,"centralContacts":28,"locations":33,"responsibleParty":49,"collaborators":51,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":75,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"University of Aberdeen","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Breast Cancer",null,"Participants with breast cancer of ductal carcinoma in-situ (DCIS) who are due to undergo surgical treatment.",[13,14],"Other: Field-Cycling Imaging research scan","Other: 3T MRI research scan",[16,20],{"type":6,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"Field-Cycling Imaging research scan","Baseline FCI scan",[9],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"3T MRI research scan","Baseline MRI scan",[9],[25],{"name":26,"affiliation":5,"role":27},"Vasiliki Mallikourti, PhD","STUDY_CHAIR",[29],{"name":26,"role":30,"phone":31,"phoneExt":10,"email":32},"CONTACT","+44 1224 437831","vasiliki.mallikourti@abdn.ac.uk",[34],{"facility":5,"status":10,"city":35,"state":10,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Aberdeen","United Kingdom","UK",{"type":39,"coordinates":40},"Point",[41,42],-2.09814,57.14369,{"lat":42,"lon":41},[45,46],{"name":26,"role":30,"phone":31,"phoneExt":10,"email":32},{"name":47,"role":30,"phone":10,"phoneExt":10,"email":48},"Gerald Lip, Dr","gerald.lip@nhs.scot",{"type":50,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[52],{"name":53,"class":54},"NHS Grampian","OTHER_GOV","100630774","breast-tumour-size-measurement-by-field-cycling-imaging-100630774",false,"NCT07492043","Breast Tumour Size Measurement by Field Cycling Imaging","BREVIA","Inclusion Criteria:\n\n* Females ≥ 18 years old.\n* Subjects diagnosed with DCIS on initial biopsy.\n* Lesion size \\>1 cm on imaging.\n* Subjects undergoing surgery as part of their treatment.\n* Able to fit comfortably in the scanners.\n* Able to understand written and spoken English.\n\nExclusion Criteria:\n\n* Subjects undergoing chemotherapy or hormonal therapy.\n* Individuals unable to give informed consent.\n* Contra-indications to MRI scanning such as implantable cardiac devices.\n* Known allergy to contrast agent.","FEMALE","18 Years",{"count":65,"type":66},12,"ESTIMATED","OBSERVATIONAL","The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can accurately estimate tumour size in patients with a type of breast cancer called ductal carcinoma in situ (DCIS). The main question it aims to answer is:\n\nCan FCI accurately estimate DCIS lesion size compared with histology results?\n\nParticipants will have a standard MRI scan and an FCI scan before undergoing surgery to remove the tumour.",[9,70],"Ductal Carcinoma In Situ",[72,73,74,9],"Field-Cycling Imaging","FCI","DCIS","NOT_YET_RECRUITING","2026-03-19",{"date":78,"type":79},"2026-03-25","ACTUAL",{"date":81,"type":66},"2026-04",{"date":83,"type":66},"2026-12",{"name":5,"class":6},1]